Mahai Chris LaVictoire bought HQL
July 16, 2026 · Form 4 insider transaction
Mahai Chris LaVictoire bought 527 shares of Abrdn Life Sciences Investors at $19.92 per share, a transaction worth $10.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
527
Price
$19.92
Total value
$10.5K
InsiderMahai Chris LaVictoire
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 16, 2026
Filing dateJuly 20, 2026
Shares owned after527
OwnershipDirect
10b5-1 planNo
AmendedNo